BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glimelius B. Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved? Acta Oncol 2015;54:433-6. [PMID: 25783749 DOI: 10.3109/0284186X.2015.1024331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nygren P, Glimelius B. Will Adjuvant Chemotherapy Improve Outcome After Preoperative (Chemo) Radiotherapy? Still More Passion than Evidence. Multidisciplinary Management of Rectal Cancer 2018. [DOI: 10.1007/978-3-319-43217-5_40] [Reference Citation Analysis]
2 Glimelius B. On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Ups J Med Sci 2017;122:1-10. [PMID: 28256956 DOI: 10.1080/03009734.2016.1274806] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
3 Glimelius B, Cavalli-Björkman N. Does shared decision making exist in oncologic practice? Acta Oncol 2016;55:125-8. [PMID: 26503517 DOI: 10.3109/0284186X.2015.1102464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Olsen RS, Andersson RE, Zar N, Löfgren S, Wågsäter D, Matussek A, Dimberg J. Prognostic significance of PLA2G4C gene polymorphism in patients with stage II colorectal cancer. Acta Oncol 2016;55:474-9. [PMID: 26364726 DOI: 10.3109/0284186X.2015.1073350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]